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Background: Wheat is one of the most common food allergens in children. The purpose of this study is to define
the natural course of wheat allergy in children with dominant gastrointestinal symptoms and identify factors that
help predict development of tolerance.
Methods: The prospective analysis covered 50 children with positive food challenge results (DBPCFC) and positive
wheat IgE test result. Resolution of wheat allergy was determined on the basis of food challenge results
(open challenge). The impact of each of the studied factors on the age when tolerance developed was assessed by
means of the Cox proportional hazard regression model.
Results: The median age of tolerance development was 69.5 months (37-192 mo.). The rates of resolution were
20% by the age of 4 years, 52% by the age of 8 years, and 66% by 12 years, and 76% by 18 years. The median age
of the tolerance development in children with peak wheat IgE level below10 kU/L was 41.4 months, with peak
wheat IgE from 10 to 19.9 kU/L was 44.5 months, with peak IgE from 20 to 49.9 kU/L – 84,9 months and with peak
IgE≥ 50 kU/L – 190.5 months. The median of the age when the highest levels of IgE for wheat were reached was
33 months (2-52 mo.) in children with resolved wheat allergy and 67 months (36-178 mo.) in children with
persistent allergy (p = .001).
Conclusions: 1. The majority of children with wheat allergy can tolerate wheat by adolescence. 2. The age when
tolerance to wheat developed depended on the level and the age of reaching the highest levels of specific IgE
for wheat. The higher the values of the above parameters, the older a child was when they developed tolerance
to wheat.
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Wheat is one of the most commonly consumed types of
grain in Europe and in America. As one of the gluten ce-
reals it is responsible for numerous diseases which are
called gluten-related disorders [1]. According to the
most recent classification they are divided into three
main groups: allergic, autoimmunological (celiac disease,
dermatitis herpetiformis) and possibly immune-mediated
(gluten sensitivity) [1]. The frequency of the former two
is about 1% each, while the third one may affect 6% of* Correspondence: grazyna.bulsa@wp.pl
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article, unless otherwise stated.population [2-5]. Although wheat is one of the most
common food allergens in children, the natural history
of the IgE-dependent allergy to wheat (WA) has been
rarely discussed in the literature [6-10].
The purpose of this study is to define the natural
course of WA in a group of children with predominant
gastrological symptoms and to identify factors that help
predict the development of tolerance.Methods
The prospective analysis covered 50 children with WA
who were the outpatients of the Gastrology Department
and the Gastrology Outpatient Clinic Pomeranian Medical
University in Szczecin and the "Zdroje" Hospital inCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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physician (an allergologist and gastroenterologist) through-
out the whole observation period. All the patients reported
gastrointestinal symptoms (vomiting, loose stools, abdom-
inal pains) and/or wheat allergy suspicion. All the patients
at initial diagnosis had positive food challenge results (with
symptoms occurring within 2 hours after wheat consump-
tion) and positive SPTas well as the levels of sIgE for wheat
(wsIgE) higher than 0.7 kU/L (Figure 1). The study was
conducted from January 1990 to May 2012.
The inclusion criteria were: diagnosed WA and con-
sent of participants and their guardians.
The criterions to exclude a child from the observation
were other chronic diseases. Only 4 children were lost to
follow-up: three children who visited the clinic only once
and one child with ulcerative colitis. Individual observa-
tions were terminated when a patient’s tolerance to wheat
(WT) had developed or when the patient turned 18.
The medical interview included questions about a pa-
tient’s age, gender, family history of allergies, coexisting al-
lergic diseases as well as other food allergies. At initial
diagnosis and at the every 1-2 years follow-up visit exami-
nations were performed including: SPT, wheat- and gluten
sIgE (wsIgE, gsIgE) tests as well as wheat challenge tests.
The analysis covered the results of tests taken at the time
of diagnosis (wsIgE1, gsIgE1) and after 1-2 years of the
elimination diet (wsIgE2, gsIgE2); the highest test results
(wsIgEmax, gsIgEmax); the results obtained during tolerance
(wsIgE3, gsIgE3). In order to investigate the dependence
between the sIgEmax level and the age when the tolerance
to wheat developed the patients were divided into 4
groups: <10 kU/L (n = 7), 10-19.9 kU/L (n = 13), 20-49.9
kU/L (n = 25) and ≥50 kU/L (n = 5).
SPTs were performed by means of commercial solu-
tions of food allergens manufactured by Allergopharma









only alimentary tract reactions
alimentary tract and skin reactions
pa
Figure 1 Type of adverse reactions to wheat during the first 18 yearsmeans the FEIA method and performed with the aid of
ImmunoCAP System (Pharmacia & Upjohn Diagnostics
AB, Uppsala, Sweden).
Food challenge tests (FC) were performed by means of
the open food challenge (OFC) or a double-blind placebo-
controlled food challenge (DBPCFC). The first challenge
test was performed as the OFC, the second - always as the
DBPCFC followed by the OFCs. Food challenges were not
repeated in children with severe anaphylactic reaction
requiring epinephrine administration. The scheme was
based on the contemporary recommendations of the Sec-
tion of Allergies and Food Intolerance of the Polish Soci-
ety of Paediatric Gastrology which followed the work of
Bock et al. [11,12]. The OFC began with the application of
a drop of wheat groats - semolina (10% wheat cooked in
water) on the upper lip. Thereafter wheat was given orally
in increasing amounts in 15-minute intervals starting from
a dose of 50 mg to reach the total of 18-20 g (3.24-3.6 g of
wheat protein). If there was no reaction to the food chal-
lenge, wheat was administered daily (>20 g of wheat) at
home for 7 days by the open method to ensure that there
were no other adverse symptoms (i.e. to rule out a co-
existing non-atopic allergy). When no adverse effects ap-
peared, WT was diagnosed. If the adverse effects had been
observed, the food challenge was abandoned and WA was
diagnosed. We diagnosed persistent wheat allergy in those
children in whom the symptoms continued in the 18th
year of age or when the observation came to an end.
To perform DBPCFC the authors used mainly liophilised
food manufactured by Apipol-Farma (in capsules) and na-
tive foods in highly hydrolysed casein (Nutramigen), or, in
other native tolerated foods. As placebo they used malto-
dextrin (117 mg) and colloidal silica (13 mg) in capsules or
other native tolerated foods.
In children whose WA had been diagnosed in infancy





Table 1 Demographic characteristics of the study patients
Characteristics No. (%) of patients; n = 50




Allergic rhinitis 17 (34)
Eosinophyllic gastrointestinal disease* 6 (12)
Eosinophilic oesophagitis 5 (10)
Other food allergies*
Milk 40 (80)




Tree nuts 13 (26)




Family history of atopy 50 (100)
1 parents 9 (18)
Both parents 41 (82)
Siblings 24 (62)
*throughout the whole observation period.
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life. In Poland it is recommended to introduce wheat in
unlimited quantities into the infant diet at that age.
Asthma, atopic dermatitis and allergic rhinitis were diag-
nosed by an attending physician (an allergologist). An IgE-
dependent allergy to other foods was diagnosed in children
who had positive food challenge (OFC or DBPCFC, de-
pending on age), and had positive SPT and/or sIgE. Ana-
phylaxis was defined as a severe reaction involving two or
more body systems or the lower respiratory tract.
The data were characterised by the median, the mini-
mum and maximum values. The development of tolerance
depending on the examined factors was assessed by means
of the Pearson Chi2 test. The Mann-Whitney test was
used to compare wheat IgE levels between the patients
with persistent allergy and the patients who had developed
tolerance. The impact of each of the studied factors on the
age of tolerance development was assessed by means of
the Cox proportional hazard regression model and pre-
sented with the Kaplan-Meier curves, while the signifi-
cance of the curves was measured with the log-rank test.
The correlation between the selected variables was evalu-
ated with the Spearman rank correlation. The tool used
for the statistical analysis was STATA 11, License No
30110532736.
The study was conducted in compliance with the Dec-
laration of Helsinki and following the consent by the
Ethical Committee of the Pomeranian Medical Univer-
sity in Szczecin (BN-001/107/90). Initially, the study was
financed from the grant No4 PO5E 086 14 of the State
Committee for Scientific Research followed by funding
from the clinic in-house research budget.
Results
A natural process of WA was analysed in 50 children -
32 boys and 18 girls from the median age of 6 months
(2-8 mo.) to 216 months (36 - 216 mo.) (Table 1).
The median age of WA diagnosis was 13 months (2-22
mo.). It did not differ significantly between the children
who developed WT and those who did not. In 32% of the
WA children the disease manifested itself as early as in in-
fancy, the number including 6% of children who devel-
oped symptoms while being breastfed. The types of
adverse reaction to wheat during diagnosis are presented
in Figure 1. They were similar to the reactions reported
before diagnosis by the patients’ parents. The parents re-
ported several of them more often than it was in case of
the FC: skin reactions (58% vs. 54%), bronchospasm (14%
vs. 10%) and abdominal pain (18% vs. 8%)
In group of the WA children 302 tests for wsIgE were
conducted. At the WA diagnosis median wsIgE1 was
8.42 kU/L (2.2-39.3 kU/L). It did not differ significantly
between the children who developed WT and those who
did not. The median of wsIgE2 was significantly higher(p = .048) in children who did not develop WT in com-
parison to those who did: 16.0 kU/L (3.2-59.3 kU/L) vs
9.12 kU/L (1.8-63.4 kU/L), respectively. The median of
wsIgEmax was also significantly higher (p = .04) in chil-
dren with persistent allergy 62.7 kU/L (36.3-72.4 kU/L)
than in those with resolved allergy 13.5 kU/L (7.9-59.3
kU/L). Disregarding the age, all the children who did not
develop WT demonstrated higher values of wsIgE than
those who did (Table 2). In the group of the WT children
the median of wsIgE3 was 3.0 kU/L (0.35-23.9 kU/L).
At the WT diagnosis the gluten specific IgE > 0.35 kU/L
was observed in 68% of children, while the concentration
at 0.7 kU/L - in 46%, with the same frequency in those
children who developed and did not develop the WT. The
value of gsIgEmax was 5 kU/L (0.35-46.9 kU/L). The me-
dians gsIgE1, gsIgE2 and gsIgEmax did not differ signifi-
cantly between the compared groups of children.
The factor that significantly distinguished both groups
was the age at which the children reached wsIgEmax.
The children with developed WT reached it earlier than
those who did not: 33 months (2-52 mo.) vs. 67 months
(36-178 mo.) (p = .001). Such dependence was not ob-
served in case of gsIgEmax.
Table 2 Median wheat IgE levels in patients with
persistent and resolved wheat allergy
Age (years) Wheat specific IgE (kU/L) p value*
Outgrown Persistent
n = 216 n = 86
0-2 9 19 .04
2-4 10 27 .03
4-6 7 49 .03
6-8 6 46 .04
8-10 6 42 .04
10-12 5 36 .05
12-14 4 35 .07
14-16 4 33 .14
16-18 4 30 .36
*Mann-Whitney test.
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period. The median of tolerance development age was
69.5 months (37-192 mo.). The rates of resolution were
20% by the age of 4 years, 52% by the age of 8 years, and
66% by 12 years, and 76% by 18 years.
The median of the tolerance development age in children
with wsIgEmax below 10 kU/L was 41.4 months, with wsI-
gEmax from 10 to19.9 kU/L – 44.5 months, with wsIgEmax
from 20 to 49.9 kU/L – 84.9 months and with wsIgEmax ≥
50 kU/L – 190.5 months. During the observation period
WT developed in 80% of children with wsIgEmax below 50
kU/L and in 40% of children with wsIgEmax ≥50 kU/L.
The study revealed that the age when WT developed
depended on the level of wsIgE2 as well as on the level
and the age of reaching wsIgEmax (Table 3, Figure 2). The
higher the values of the above parameters were, the older
a child was when they developed WT. Other factors such
as gender, family history of atopy, the age at the WA diag-
nosis, the type of the adverse reaction to food challenge,
the number and kind of other food allergens, coexistence
of another allergic disease, the level of wsIgE1, gsIgE1,Table 3 The impact of chosen factors on the tolerance develop
Parameter n
Wheat IgE1 [kU/L] 50
Wheat IgE2 [kU/L] 50
Wheat IgEmax [kU/L] 50
Gluten IgEmax [kU/L] 34
Age of wheat allergy diagnosis [mo.] 50
Age of wheat sIgEmax [mo.] 50
Number of food allergens 50
Coexistence of another allergic disease 50
IgE1: diagnosis, IgE2: 1-2 years after diagnosis; r – correlation coefficient.gsIgE2 and gsIgEmax did not have any significant effect on
the age when WT developed.
In children who developed WT a significant correlation
was observed between the age of tolerance development
and the level of wsIgEmax (r = .82, p < .001) (Figure 3).
Discussion
The paper presents the natural history of WA in children
with predominant gastrointestinal symptoms. They affected
88% of patients and mainly included vomiting (62%) and
loose stools (44%). Abdominal pain was rarely reported
(8%), which results from the patients’ young age. There
have been no similar descriptions in the literature. Few
publications presenting the WA course dealt mainly with
children with dominating skin and respiratory symptoms as
well as with anaphylaxis [6-10].
Similar to other authors, we found that children with
WA have high atopic potential. They come from families
with history of atopy [6,7]. Over the years most of them
develop other atopic diseases, most frequently atopic
dermatitis (78%), allergic rhinitis (64%) and asthma
(48%) [6,7,9]. They suffer from food allergies, particularly
to milk (80%), egg white (72%) and peanuts (50%), but
also to other nuts, fish and soya [6,7].
In the study group the median of WA diagnosis age was
13 months (2-22 mo.). In one third of the children the
WA signs appeared in infancy and in 6% during breast-
feeding. In all the children other food allergies had been
diagnosed before wheat. As in other studies the median of
the food allergy diagnosis age was 3 months (1-8 mo.)
[7,9]. Some authors quote higher age of the WA diagnosis
[6,13]. Most patients (76%) had developed WT before
reaching maturity. The WTage was 5.5 years (3-16 y.).
According to other authors the IgE-dependent allergy to
milk or hen egg requires similar periods of elimination
diet. In their studies 60% to 80% of patients reached toler-
ance also at the age of 8-12 years [14-16]. Worse progno-
sis was reported for children with IgE-dependent allergy
to peanuts and other nuts as well as to sesame seed. Onlyment age in children with IgE-dependent allergy to wheat










Figure 2 Relationship of peak wheat IgE level to persistence of wheat allergy during the first 18 years of life.
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of cases the allergy continued into adulthood [17].
The risk of continued WA was high in those diag-
nosed children who, despite the elimination diet, had
been demonstrating rising wsIgE for several years. The
median of age in which those children reached max-
imum concentration of wsIgE was 5.5 years (3-14.5 yr).
In children who developed WT, after 1-2 years of diet
the median of wsIgE did not differ significantly from the
level at diagnosis. Those children reached maximum
concentrations of wsIgE as early as at 2.7 years of age (2
mo.-4.5 yr.). Then the wsIgE values fell, but in some
children they did not return to the level below 0.7 kU/L.
An important factor that modified the WT age was the
level of wsIgEmax. There was a significant difference be-
tween the children with wsIgEmax below 20 kU/L, at 20-
50 kU/L and over 50 kU/L. Their tolerance age medians
were, respectively: 3.5 years, 7 years and 16 years. There
was no relevant difference between the children with
wsIgE below 10 kU/L and at 10-20 kU/L.
Having determined both the age when wsIgEmax was
reached and its actual value, we can predict the further
course of the disease [6,18,19]. Reaching wsIgEmax in
older age is an important factor increasing the risk thatFigure 3 The curve of the correlation of the peak wheat sIgE level withe allergy will continue into adulthood. Such children
demonstrate fast rising wsIgE in the initial period of the
diet and maintain its high levels in the subsequent years
(often >50 kU/L). The consumption of wheat leads to
the signs of anaphylaxis. In our study the specific IgE for
gluten did not display such dependence and therefore
we believe that it is unlikely to provide any benefit in
clinical practice and it is not important from the clinical
point of view.
What was characteristic of the children with WT were
persistently high levels of wsIgE – their median reached
3 kU/L (0.35-23.9 kU/L) [6,10]. There could be several
reasons for this. The first reason are cross reactions
among the water- and salt soluble wheat grain and
pollen proteins responsible for the false positive results
[20]. The second reason is insufficient knowledge about
the wheat grain allergens. Solutions used for SPTs or for
determining sIgE for wheat do not contain all the wheat
grain allergens. The example is rω-5 gliadin which must
be determined independently [10]. And thirdly, it is
likely that, as in the case of allergies to milk or hen egg,
different epitopes are recognised by antibodies of the pa-
tients who will develop tolerance and of the ones whose
allergy will continue [21]. Battais et al. proved that IgEth the wheat tolerance development age.
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duced anaphylaxis (WDEIA), anaphylaxis and urticaria
detected sequential epitopes in the repetitive domain of
gliadins, whereas the IgE of atopic dermatitis patients
probably recognized conformational epitopes [22].
In milk, hen egg and peanuts allergies the reduction in
SPT and the reduction of sIgE concentration below a cut-
off are popular indicators of the high likelihood of losing
clinical reactivity by allergic people [14,15,18,23-25]. In
such cases the assessment of the sIgE values in subsequent
years of elimination diet is a useful tool to prognosticate
tolerance.
As other researchers have found, the volume of sIgE
concentration is not a useful factor of the clinical reactivity
to wheat [10,26]. Using the CAP system, the positive pre-
dictive value of wheat sIgE remained less than 75% [26].
In recent years a new wheat allergen, the recombinant rω-
5-gliadin (Tri a 19), has been discovered in patients with
anaphylaxis and with WDEIA. High concentrations of IgE
for the recombinant rω-5-gliadin correlate with the sever-
ity of response as well as with the wheat volume in a food
challenge test., which gives hope that the cut-off value can
be determined giving the maximum efficiency of the rω-5-
gliadin test for the positive wheat challenge [8,10,27-29].
In other forms of WA the rω-5 gliadin-specific IgE is less
frequent – it is observed in just 30% of patients. Moreover,
in these groups of patients there is no correlation between
the concentration of the rω-5 gliadin-specific IgE and food
challenge test results [30].
In conclusion, children with WA demonstrating pre-
dominant gastrointestinal symptoms develop WT in child-
hood - 2/3 of them by the age of 10. In the majority of
cases it is not related to normalisation of wsIgE, which can
remain high. The level and age of peak level of wsIgE are
an important factor enabling us to predict when WT will
appear. Coexisting allergic diseases and allergies to other
foods are not the factors of negative prognosis.Abbreviations
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